Altmetric
Isolated small airways obstruction predicts future chronic airflow obstruction: A multinational longitudinal study
File | Description | Size | Format | |
---|---|---|---|---|
e002056.full.pdf | Published version | 1.38 MB | Adobe PDF | View/Open |
Title: | Isolated small airways obstruction predicts future chronic airflow obstruction: A multinational longitudinal study |
Authors: | Knox-Brown, B Potts, J Quintero Santofimio, V Minelli, C Patel, J Abass, N Agarwal, D Ahmed, R Anand, M B.S., J Denguezli, M Franssen, F Gislason, T Janson, C Juvekar, S Koul, P Malinovschi, A Nafees, A Nielsen, R Paraguas, S Buist, AS Burney, P Amaral, A |
Item Type: | Journal Article |
Abstract: | Background Chronic airflow obstruction is a key characteristic of chronic obstructive pulmonary disease. We investigated whether isolated small airways obstruction is associated with chronic airflow obstruction later in life. Methods We used longitudinal data from 3957 participants of the multinational Burden of Obstructive Lung Disease study. We defined isolated small airways obstruction using the prebronchodilator mean forced expiratory flow rate between 25% and 75% of the forced vital capacity (FVC) (FEF25–75) if a result was less than the lower limit of normal (<LLN) in the presence of a normal forced expiratory volume in 1 s to FVC ratio (FEV1/FVC). We also used the forced expiratory volume in 3 s to FVC ratio (FEV3/FVC) to define small airways obstruction. We defined chronic airflow obstruction as post-bronchodilator FEV1/FVC<LLN. We performed mixed effects regression analyses to model the association between baseline isolated small airways obstruction and chronic airflow obstruction at follow-up. We assessed discriminative and predictive ability by calculating the area under the receiver operating curve (AUC) and Brier score. We replicated our analyses in 26 512 participants of the UK Biobank study. Results Median follow-up time was 8.3 years. Chronic airflow obstruction was more likely to develop in participants with isolated small airways obstruction at baseline (FEF25-75 less than the LLN, OR: 2.95, 95% CI 1.02 to 8.54; FEV3/FVC less than the LLN, OR: 1.94, 95% CI 1.05 to 3.62). FEF25-75 was better than the FEV3/FVC ratio to discriminate future chronic airflow obstruction (AUC: 0.764 vs 0.692). Results were similar among participants of the UK Biobank study. Conclusion Measurements of small airways obstruction can be used as early markers of future obstructive lung disease. |
Issue Date: | 20-Nov-2023 |
Date of Acceptance: | 7-Nov-2023 |
URI: | http://hdl.handle.net/10044/1/107999 |
DOI: | 10.1136/bmjresp-2023-002056 |
ISSN: | 2052-4439 |
Publisher: | BMJ Publishing Group |
Journal / Book Title: | BMJ Open Respiratory Research |
Volume: | 10 |
Issue: | 1 |
Copyright Statement: | © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
Publication Status: | Published |
Article Number: | ARTN e002056 |
Online Publication Date: | 2023-11-20 |
Appears in Collections: | Department of Infectious Diseases National Heart and Lung Institute Faculty of Medicine |
This item is licensed under a Creative Commons License